1Griendling KK,Sorescu D,Ushio-Fukai M.NAD(P)H oxidase:role in cardiovascular biology and disease[J].Circ Res,2000,86(5):494-501.
2Sorescu D,Weiss D,Lassègue B,et al.Superoxide production and expression of nox family proteins in human atherosclerosis[J].Circulation,2002,105(12):1429-1435.
3Zalba G,Fortuno A,Orbe J,et al.Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9:implications for human atherosclerosis[J].Arterioscler Thromb Vasc Biol,2007,27(3):587-593.
4Edirimanne VE,Woo CW,Siow YL,et al.Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats[J].Can J Physiol Pharmacol,2007,85(12):1236-1247.
5Whitehead AS,FitzGerald GA.Twenty-first century phox:not yet ready for widespread screening[J].Circulation,2001,103(1):7-9.
6Guzik TJ,West NE,Black E,et al.Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis[J].Circulation,2000,102(15):1744-1747.
7Arca M,Conti B,Montali A,et al.C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery disease[J].Arterioscler Thromb Vasc Biol,2008,28(4):752-757.
8Spence MS,McGlinchey PG,Patterson CC,et al.Investigation of the C242T polymorphism of NAD(P)H oxidase p22phox gene and ischaemic heart disease using family-based association methods[J].Clin Sci(Lond),2003,105(6):677-682.
9Hayaishi-Okano R,Yamasaki Y,Kajimoto Y,et al.Association of NAD(P)H oxidase p22phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes[J].Diabetes Care,2003,26(2):458-463.
10Moreno MU,San José G,Orbe J,et al.Preliminary characterisation of the promoter of the human p22(phox) gene:identification of a new polymorphism associated with hypertension[J].FEBS Lett,2003,542(1-3):27-31.
